EPEN-10. 5-FU ENHANCES RADIATION THERAPY IN IN VITRO AND IN VIVO TREATMENT OF 1q+ PFA EPENDYMOMA

BACKGROUND: Chemotherapy trials in relapsed pediatric ependymoma trials have failed to show reproducible benefit. High-risk 1q+PFA ependymoma show have a particularly bad outcome, with radiation and surgery showing no benefit at relapse. Using two 1q+PFA1 cell lines, we identified several ependymoma...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neuro Oncol
Glavni autori: Griesinger, Andrea, Donson, Andrew, Amani, Vladimir, Domman, Andrew, Pierce, Angela, Court, Benjamin Van, Karam, Sana, Steiner, Jenna, Serkova, Natalie, Dorris, Kathleen, Foreman, Nicholas
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
Ependymoma
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477225/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz036.067
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items